Elizabeth Lloyd, MD
Clinical Associate Professor of Pediatrics
Medical Director, C&W Medication Safety and Physician Advisor for Antimicrobial Stewardship
Pediatrics
Infectious Diseases
Medical School
Available to mentor
Elizabeth Lloyd, MD
Clinical Associate Professor
Manage Your Profile
About
Dr. Lloyd sees patients in the hospital and clinic setting as part of the Pediatric Infectious Diseases division. Scholarly activities center on the use of antimicrobials in children, with a more recent focus on prescribing in the outpatient setting, via both quality improvement work and research. She has served as the pediatric physician lead on the Ambulatory Antimicrobial Stewardship Program since its inception in 2020. As a part of this program, she is closely involved in developing and updating clinical guidelines, providing education and individualized feedback to various provider groups, developing electronic medical record-based tools, and creating metrics and dashboards to track outpatient prescribing.
Qualifications
-
Pediatric Infectious Diseases FellowshipUniversity of Michigan Medical School, Ann Arbor, United States
2016 - 2019
-
Pediatric ResidencyUniversity of Michigan Medical School, Ann Arbor, United States
2013 - 2016
-
MDUniversity of Michigan Medical School, Ann Arbor, MI, United States
2009 - 2013
-
BAKalamazoo College, Kalamazoo, MI, United States
2005 - 2009
Research Overview
Research is focused on the impact of stewardship interventions on antimicrobial use in both hospitalized and outpatient children.
Recent Publications
-
Lloyd EC, Dillman NO, Tribble AC, Wu L, Seidl S, Burrows HL, Petty LA. Infect Control Hosp Epidemiol, 2024 Mar; 45 (3): 395 - 397.Journal ArticleImpact of an electronic medical-record-embedded clinical-decision support tool on duration of antibiotics for outpatient pediatric skin and soft-tissue infections.
DOI:10.1017/ice.2023.232 PMID: PMC10933496 -
Sherman G, Lamb GS, Sharma TS, Lloyd EC, Nagel J, Dandam NN, Oliveira CR, Sheikha HS, Anosike BI, Lee P, Vora SB, Patel K, Sue PK, Rubbab B, Yarbrough AM, Ganapathi L, Nakamura MM. J Pediatric Infect Dis Soc, 2023 Apr 18; 12 (3): 152 - 155.Journal ArticleMonoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.
DOI:10.1093/jpids/piac124 PMID: PMC10112679 -
Lloyd EC, Cogen JD, Maples H, Bell SC, Saiman L. J Pediatric Infect Dis Soc, 2022 Sep 7; 11 (Supplement_2): S53 - S61.Journal ArticleAntimicrobial Stewardship in Cystic Fibrosis.
DOI:10.1093/jpids/piac071 PMID: 36069899 -
Lloyd EC, Martin ET, Dillman N, Nagel J, Chang R, Gandhi TN, Tribble AC. J Pediatric Infect Dis Soc, 2021 Apr 3; 10 (3): 282 - 288.Journal ArticleImpact of a Best Practice Advisory for Pediatric Patients With Staphylococcus aureus Bacteremia.
DOI:10.1093/jpids/piaa058 PMID: 32531048 -
Lloyd EC, Gandhi TN, Petty LA. JAMA, 2021 Mar 9; 325 (10): 1015Journal ArticleMonoclonal Antibodies for COVID-19.
DOI:10.1001/jama.2021.1225 PMID: 33544136 -
Micic D, Rao K, Trindade BC, Walk ST, Chenoweth E, Jain R, Trivedi I, Santhosh K, Young VB, Aronoff DM. Infect Dis Rep, 2015 Aug 11; 7 (3): 5979Journal ArticleSerum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.
DOI:10.4081/idr.2015.5979 PMID: PMC4593886 -
Rao K, Micic D, Chenoweth E, Deng L, Galecki AT, Ring C, Young VB, Aronoff DM, Malani PN. Journal of the American Geriatrics Society, 2013 Oct 1; 61 (10): 1738 - 1742.Journal ArticlePoor functional status as a risk factor for severe clostridium difficile infection in hospitalized older adults
DOI:10.1111/jgs.12442 PMID: 24083842 -
Rao K, Walk ST, Micic D, Chenoweth E, Deng L, Galecki AT, Jain R, Trivedi I, Yu M, Santhosh K, Ring C, Young VB, Huffnagle GB, Aronoff DM. PLoS One, 2013 8 (3): e58265Journal ArticleProcalcitonin levels associate with severity of Clostridium difficile infection.
DOI:10.1371/journal.pone.0058265 PMID: PMC3591407
Featured News & Stories
Department News
Department of Pediatrics Faculty Promotions
U-M faculty across pediatrics, cardiology, psychology & more were promoted in 2025, recognizing excellence in clinical and academic leadership.
